Cipla Elores

Description

Elores 1.5 gm Injection / Elores 3 gm Injection (by Cipla) is a novel anti‑infective antibiotic medicine used to treat serious bacterial infections, especially those caused by resistant gram‑negative bacteria. It combines ceftriaxone (a third‑generation cephalosporin), sulbactam (a beta‑lactamase inhibitor) and an antibiotic‑resistance breaker (EDTA) to restore and enhance antibiotic effectiveness against resistant organisms. Elores is typically given by injection under medical supervision in hospital or critical care settings. It helps manage life‑threatening infections and is part of efforts to address antimicrobial resistance. Use is guided by a doctor based on the type and severity of infection.